Ziltivekimab Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation (Novo Nordisk)

Protocol Name: ZEUS – A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation Sponsor: Novo Nordisk Indication: Dual Diagnosis of Chronic Kidney Disease & Cardiovascular Disease Primary Investigator: Ankit Mehta, MD Location: Dallas Transplant Institute, 3604 Live Oak Street, Suite 100, Dallas, …

Ziltivekimab Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation (Novo Nordisk) Read More »